Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
12. November 2024 09:15 ET
|
Sonnet BioTherapeutics Holdings, Inc.
Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent covering a variant of IL-18 incorporated into two novel immunotherapeutic drug...